Stay updated with breaking news from Clinical Research Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...
Virtual gathering delivers the latest cancer science to the global community...
Verano to Add Cultivation and Fortify Retail Capacity in Pennsylvania April 22, 2021 07:00 ET | Source: Verano Holdings Corp. Verano Holdings Corp. Chicago, UNITED STATES Adds cultivation and production in Pennsylvania, with an active and completely built-out, state-of-the-art 62,000 sq. ft. indoor facility in the country’s fifth most populous state. Gives the Company the ability to further develop its retail footprint with equity in a permit to open six dispensaries, and a second cultivation and production facility. CHICAGO, April 22, 2021 (GL...
April 22, 2021 at 7:33 am Published by NCV Newswire Verano to Add Cultivation and Fortify Retail Capacity in Pennsylvania Adds cultivation and production in Pennsylvania, with an active and completely built-out, state-of-the-art 62,000 sq. ft. indoor facility in the country’s fifth most populous state. Gives the Company the ability to further develop its retail footprint with equity in a permit to open six dispensaries, and a second cultivation and production facility. CHICAGO, April 22, 2021 (GLOBE NEWSWIRE) — Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or ...
Share this article Share this article SHANGHAI, April 8, 2021 /PRNewswire/ -- Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel target discovery and development of novel therapeutics, today announced the appointment of Dr. Eric Rowinsky, President and Executive Chairman of the Board of Rgenix, Inc., and Dr. Manuel Hidalgo, Chief of Hematology and Medical Oncology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, to its Scientific Advisory Board. Drs. Rowinsky and Hidalgo will bring their strong expertise in translational and clinical...